Stereoselective pharmacokinetics of disopyramide and interaction with cimetidine.
The pharmacokinetics of each of the enantiomers of disopyramide were examined after i.v. bolus administration of 150 mg racemic drug in a randomized cross-over study before and after the administration of cimetidine 400 mg twice daily orally. Clearance and volume of distribution (Vz) of total drug were significantly (P less than 0.001) higher for the R-(-) enantiomer than the S-(+) enantiomer (7.9 vs 4.6 l h-1 and 89 vs 50 l, respectively), whereas no significant difference in half-life could be demonstrated. The clearance of free drug was significantly (P less than 0.05) higher for the S-(+) enantiomer than that of the R-(-) enantiomer (34.6 +/- 5.4 l h-1 vs 27.2 +/- 5.6 l h-1), whereas no significant enantioselective difference in unbound volumes of distribution (258 +/- 38 l vs 226 +/- 42 l) could be demonstrated. Coadministration of cimetidine did not alter the pharmacokinetics of disopyramide. A significant concentration- or time-related decrease in the renal clearance of each of the enantiomers measured with respect to total drug in serum was observed, whereas renal clearances of the free enantiomers were similar.
Bonde
J
J
Department of Anaesthesiology and Intensive Care Medicine, KAS Herlev, Denmark.
Pedersen
L E
LE
Nygaard
E
E
Ramsing
T
T
Angelo
H R
HR
Kampmann
J P
JP
D000328:Adult; D002927:Cimetidine / Q000494:pharmacology*; D004206:Disopyramide / Q000493:pharmacokinetics*; D004347:Drug Interactions; D006801:Humans; D008297:Male; D012016:Reference Values; D013237:Stereoisomerism
D002927:Cimetidine; D004206:Disopyramide